Asthika Goonewardene
Senior Managing Director, Emerging Rare DiseaseAsthika Goonewardene is a Senior Managing Director and Senior Research Analyst covering Oncology at Leerink Partners.
Mr. Goonewardene has nearly two decades of experience covering the biopharma sector, with a focus on innovative cancer therapies across a broad range of modalities.
Prior to joining Leerink Partners, Mr. Goonewardene was a Managing Director and Senior Biotechnology Analyst at Truist Securities. Previously, he was a Senior Biotechnology Analyst at Bloomberg Intelligence, where he led coverage of the global biotechnology sector. Earlier in his career, he held roles in biotechnology equity research, consulting, and in industry.
Mr. Goonewardene holds a Bachelor of Science in Biotechnology and an MBA from Rochester Institute of Technology.
